Format

Send to

Choose Destination
See comment in PubMed Commons below
J R Soc Interface. 2014 May 7;11(96):20140206. doi: 10.1098/rsif.2014.0206. Print 2014 Jul 6.

Mathematical models of the transitions between endocrine therapy responsive and resistant states in breast cancer.

Author information

1
Graduate Program in Genetics, Bioinformatics and Computational Biology, Virginia Polytechnic Institute and State University, , Blacksburg, VA 24061, USA.

Abstract

Endocrine therapy, targeting the oestrogen receptor pathway, is the most common treatment for oestrogen receptor-positive breast cancers. Unfortunately, these tumours frequently develop resistance to endocrine therapies. Among the strategies to treat resistant tumours are sequential treatment (in which second-line drugs are used to gain additional responses) and intermittent treatment (in which a 'drug holiday' is imposed between treatments). To gain a more rigorous understanding of the mechanisms underlying these strategies, we present a mathematical model that captures the transitions among three different, experimentally observed, oestrogen-sensitivity phenotypes in breast cancer (sensitive, hypersensitive and independent). To provide a global view of the transitions between these phenotypes, we compute the potential landscape associated with the model. We show how this oestrogen response landscape can be reshaped by population selection, which is a crucial force in promoting acquired resistance. Techniques from statistical physics are used to create a population-level state-transition model from the cellular-level model. We then illustrate how this population-level model can be used to analyse and optimize sequential and intermittent oestrogen-deprivation protocols for breast cancer. The approach used in this study is general and can also be applied to investigate treatment strategies for other types of cancer.

KEYWORDS:

breast cancer; endocrine resistance; intermittent treatment; potential landscape; sequential treatment

PMID:
24806707
PMCID:
PMC4032535
DOI:
10.1098/rsif.2014.0206
[Indexed for MEDLINE]
Free PMC Article
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for HighWire Icon for PubMed Central
    Loading ...
    Support Center